AtriCure, Inc. (ATRC)
47.79
-0.56
(-1.16%)
USD |
NASDAQ |
Sep 01, 11:11
AtriCure Cash from Operations (TTM) : 64.94M for June 30, 2026
Cash from Operations (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 64.94M |
| March 31, 2026 | 64.36M |
| December 31, 2025 | 57.33M |
| September 30, 2025 | 42.07M |
| June 30, 2025 | 35.36M |
| March 31, 2025 | 21.98M |
| December 31, 2024 | 11.14M |
| September 30, 2024 | 10.40M |
| June 30, 2024 | -8.084M |
| March 31, 2024 | -13.31M |
| December 31, 2023 | 4.424M |
| September 30, 2023 | 0.44M |
| June 30, 2023 | -2.866M |
| March 31, 2023 | -1.648M |
| December 31, 2022 | -22.14M |
| September 30, 2022 | -21.89M |
| June 30, 2022 | -20.33M |
| March 31, 2022 | -29.10M |
| December 31, 2021 | -13.78M |
| September 30, 2021 | -10.13M |
| June 30, 2021 | -6.114M |
| March 31, 2021 | -13.13M |
| December 31, 2020 | -19.90M |
| September 30, 2020 | -27.39M |
| June 30, 2020 | -33.46M |
| Date | Value |
|---|---|
| March 31, 2020 | -18.16M |
| December 31, 2019 | -15.81M |
| September 30, 2019 | -11.30M |
| June 30, 2019 | -3.794M |
| March 31, 2019 | -8.474M |
| December 31, 2018 | -4.171M |
| September 30, 2018 | -3.678M |
| June 30, 2018 | -8.76M |
| March 31, 2018 | -8.882M |
| December 31, 2017 | -8.994M |
| September 30, 2017 | -9.711M |
| June 30, 2017 | -8.766M |
| March 31, 2017 | -13.73M |
| December 31, 2016 | -15.12M |
| September 30, 2016 | -19.96M |
| June 30, 2016 | -18.40M |
| March 31, 2016 | -9.865M |
| December 31, 2015 | -7.904M |
| September 30, 2015 | -5.837M |
| June 30, 2015 | -9.683M |
| March 31, 2015 | -16.17M |
| December 31, 2014 | -21.60M |
| September 30, 2014 | -22.75M |
| June 30, 2014 | -20.86M |
| March 31, 2014 | -17.14M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| Boston Scientific Corp. | 4.529B |
| Abbott Laboratories | 9.905B |
| AngioDynamics, Inc. | 3.089M |
| Alphatec Holdings, Inc. | 56.52M |
| Baxter International, Inc. | 1.319B |